2016
DOI: 10.1001/jama.2016.6423
|View full text |Cite
|
Sign up to set email alerts
|

Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
34
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 84 publications
(39 citation statements)
references
References 39 publications
3
34
0
2
Order By: Relevance
“…However, this issue should be carefully considered from multiple perspectives, including cost, benefit, and the harm of taking blood samples from healthy children and adolescents. According to the United States Preventive Services Task Force, the current evidence is insufficient to assess the usefulness of screening for lipid disorders in children and adolescents [ 24 , 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, this issue should be carefully considered from multiple perspectives, including cost, benefit, and the harm of taking blood samples from healthy children and adolescents. According to the United States Preventive Services Task Force, the current evidence is insufficient to assess the usefulness of screening for lipid disorders in children and adolescents [ 24 , 25 ].…”
Section: Discussionmentioning
confidence: 99%
“…Dyslipidemia in studied children was defined as an abnormal lipid profile value in at least one of: LDL-cholesterol (≥ 130 mg/dL), total cholesterol (TC) (≥ 200 mg/dL), HDL-cholesterol (< 40 mg/dL) and/or triglycerides (TG) (in children 0-9 years ≥ 100 mg/dL, and in those aged 10-19yrs ≥ 130 mg/dL) [38][39][40].…”
Section: Blood Collectionmentioning
confidence: 99%
“…Risk factors such as hypertension, dyslipidemia, and adiposity may contribute to the development of CVD. Dyslipidemia is characterized by abnormal blood lipid levels, such as increased low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC) and decreased high-density lipoprotein cholesterol (HDL-C) [ 2 ]. Dyslipidemia is a risk factor for the development of CVD and an important topic of research [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Dyslipidemia is characterized by abnormal blood lipid levels, such as increased low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC) and decreased high-density lipoprotein cholesterol (HDL-C) [ 2 ]. Dyslipidemia is a risk factor for the development of CVD and an important topic of research [ 2 ]. Recently, chromosomal regions and specific genes such as cholesterol ester transfer protein (CETP) and scavenger receptor class B type 1 (SCARB1) have been proposed to be associated with blood lipid levels [ 3 ].…”
Section: Introductionmentioning
confidence: 99%